Transdermal delivery of desmopressin using a coated microneedle array patch system.
暂无分享,去创建一个
Mahmoud Ameri | M. Ameri | M. Cormier | K. Nyam | P. Daddona | B. Johnson | Luz Libiran | Dee Dee Zhang | Michel Cormier | Bonny Johnson | Kofi Nyam | Luz Libiran | Pete Daddona
[1] T Terahara,et al. Determination of threshold energy dose for ultrasound-induced transdermal drug transport. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[2] S L Jacques,et al. Mid-infrared laser ablation of stratum corneum enhances in vitro percutaneous transport of drugs. , 1991, The Journal of investigative dermatology.
[3] T. Okano,et al. Pulsatile drug delivery , 1989 .
[4] M. Cormier,et al. Transdermal Delivery of Antisense Oligonucleotides with Microprojection Patch (macroflux®) Technology , 2001, Pharmaceutical Research.
[5] H. Maibach,et al. Diseased skin models in the hairless guinea pig: in vivo percutaneous absorption. , 1990, Dermatologica.
[6] N. Peppas,et al. Pulsatile Drug Delivery: Current Applications and Future Trends , 1993 .
[7] S. Das,et al. A dose-related curve of wound tensile strength following ultraviolet irradiation in the hairless guinea pig. , 1991, The American journal of the medical sciences.
[8] J. Marty,et al. In vivo evaluation in man by two noninvasive methods of the stratum corneum barrier function after physical and chemical modifications , 1991, International journal of cosmetic science.
[9] A. Malick,et al. Effect of iontophoresis on in vitro skin permeation of an analogue of growth hormone releasing factor in the hairless guinea pig model. , 1992, Journal of pharmaceutical sciences.
[10] K. Hjälmås,et al. Efficacy, Safety, and Dosing of Desmopressin For Nocturnal Enuresis in Europe , 1993, Clinical pediatrics.
[11] M. Southam,et al. Reproducible fentanyl doses delivered intermittently at different time intervals from an electrotransport system. , 1999, Journal of pharmaceutical sciences.
[12] Sueki. Hairless guinea pig skin: anatomical basis for studies of cutaneous biology , 2000, European journal of dermatology : EJD.
[13] J. Serup,et al. Topical D‐vitamins: multiparametric comparison of the irritant potential of calcipotriol, tacalcitol and calcitriol in a hairless guinea pig model , 1997, Contact dermatitis.
[14] P. Höglund,et al. Pharmacokinetics of 1‐deamino‐8‐d‐arginine vasopressin after various routes of administration in healthy volunteers , 1993, Clinical endocrinology.
[15] M. Allen,et al. Microfabricated microneedles: a novel approach to transdermal drug delivery. , 1998, Journal of pharmaceutical sciences.
[16] Y. Tsai,et al. The effect of pretreatment by penetration enhancers on the in vivo percutaneous absorption of piroxicam from its gel form in rabbits , 1991 .
[17] B. W. Barry,et al. Skin absorption enhancers. , 1992, Critical reviews in therapeutic drug carrier systems.
[18] J. Matriano,et al. Macroflux® Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization , 2004, Pharmaceutical Research.
[19] S. Mitragotri,et al. Ultrasound-mediated transdermal protein delivery , 1995, Science.
[20] J. Stocker. Comparison of a multiple puncture tuberculin test with purified protein derivative. , 1967, The American review of respiratory disease.
[21] S. Lundin,et al. Administration of antidiuretic peptide (DDAVP) by way of suction de-epithelialised skin , 1991, The Lancet.
[22] M. Cormier,et al. Macroflux Technology for Transdermal Delivery of Therapeutic Proteins and Vaccines , 2002 .
[23] S. Lundin,et al. Absorption of an Oxytocin Antagonist (Antocin) and a Vasopressin Analogue (dDAVP) Through a Standardized Skin Erosion in Volunteers , 1995, Pharmaceutical Research.